Company intelligence / Profile preview

Guangzhou Jiangzheng Pharmaceutical Technology

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangzhou Jiangzheng Pharmaceutical Technology is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company leverages its expertise in medicinal chemistry and drug design to target high-value pathways in oncology and immunology, with a particular emphasis on kinase inhibitors. Their lead programs include selective inhibitors for Janus kinases and fibroblast growth factor receptors. In addition to its internal pipeline, the company provides specialized research and development services to the broader pharmaceutical industry.

Therapeutic areas: ImmunologyHematologyOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Guangzhou Jiangzheng Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Jiangzheng Pharmaceutical Technology.

Explore the full profile